Superseded public profile

U.S. label recordEndocrine

Superseded · version 1: Tesamorelin

Related names recorded in this version: Egrifta

A growth-hormone-releasing factor analogue represented in U.S. drug-label records.

This is preserved historical wording.
It is no longer the current profile. Read the current profile and its correction notice.

What this version reported

The cited DailyMed label identifies Tesamorelin and contains the product's official indications and warnings. This profile links to the label without restating it as medical guidance.

Organizations named in cited records:
  • U.S. National Library of Medicine

Sources for this version

  1. 1
    EGRIFTA SV (tesamorelin) kit · SPL version 8 · published 2026-01-02 ↗

    DailyMed · U.S. National Library of Medicine · Official source · Source checked July 22, 2026